Maggie Cheung
Senior Director, Health Economics and Outcomes Research @Regeneron
Signup · Get unlimited contacts
WORK HISTORY
Senior Director, Health Economics and Outcomes Research @Regeneron
Regeneron\'s flagship products include EYLEA, an anti-VEGF drug used to treat retinal vein blockage and age-related macular degeneration, and Dupixent, a monoclonal antibody drug used to treat inflammatory diseases such as eczema, asthma and nasal polyps.
EDUCATION
Sichuan University
Master of Science - MS
Sichuan University
Bachelor of Science - BS
University of Illinois Chicago
Doctor of Philosophy - PhD
ABOUT MAGGIE CHEUNG
With multidisciplinary training in health economics, epidemiology, pharmacy, and pharmaceutical sciences, I have enjoyed working with fellow colleagues, clinicians, and payers, to understand the real world value of innovative medicines and optimize access to effective treatments for patients need. The most rewarding moments of my career are the times when knowing my work has had a positive impact, even the slightest sometimes, on the patients and their families\' quality of life.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.